Antonella Cianferoni

Antonella Cianferoni, MD, PhD, is an associate professor in pediatrics at the Perelman School of Medicine, University of Pennsylvania, and the medical director of the Food Allergy Immunotherapy program at the Children’s Hospital of Philadelphia (CHOP). Dr. Cianferoni is responsible for describing for the first time how iNKT and T cells contribute to food allergy pathogenesis, including EoE- and IgE-mediated food allergies. She also contributed to the identification of TSLP, EMSY, and CAPN14 as genetic risk factors for EoE. Dr. Cianferoni was PI of the first-ever study aimed to modify the course of EoE by inducing tolerance to milk allergen by epicutaneous immunotherapy, and co-investigator of many clinical trials.   

She is part of the multidisciplinary team of the Center for Treatment and Research of Pediatric Eosinophilic Gastrointestinal Disorders. As medical director of CHOP, she developed a multi-food immunotherapy protocol to treat patients with complex food allergies. She is currently studying the safety and efficacy of such protocols and how they influence the development of EoE. Dr. Cianferoni is the past Chair of the Workgroup of Eosinophilic Esophagitis at the EAACI and in the medical board of iFPIES group.